BridgePoint Bio Newsletter
Subscribe
Sign in
Home
Archive
About
Do we have a plan for affordable genetic medicine?
The short answer is 'no', but we could build out this path in the next decade.
Sep 19, 2024
•
Kevin Curran
3
1
Latest
Top
Discussions
Commercial issues with gene editing
The science has turned a corner but the financial side remains murky and difficult.
Sep 5, 2024
•
Kevin Curran
Germline gene editing...might we be accidentally modifying the human lineage?
Designing a gene editing clinical trial requires a thoughtful approach towards the accidental editing of sperm and egg cells.
Jul 1, 2024
•
Kevin Curran
How can VLPs help us advance gene editing medicine?
Let's talk about Virus Like Particles... Here, I present part 3 from my video series on gene editing delivery.
Jun 17, 2024
•
Kevin Curran
How are LNPs used to deliver gene editing tools into the human body?
Crispr/Cas9 is working well...but we're still learning how to move this cargo into specific cells. (2/3)
May 21, 2024
•
Kevin Curran
1
How can we deliver gene editing tools into the human body?
Crispr/Cas9 is working well...but we're still learning how to move this cargo into the correct cells. (1/3)
May 7, 2024
•
Kevin Curran
1
How does the new gene editing drug work?
I present a short video describing how Casgevy works for Sickle Cell Disease
Apr 16, 2024
•
Kevin Curran
1
Watch my you tube video on gene editing challenges
I discuss a recent safety issue with base editing technology
Apr 12, 2024
•
Kevin Curran
1
See all
BridgePoint Bio Newsletter
I write about advanced medicine in an approachable manner. My newsletter topics include gene editing, new strategies to cure disease and artificial intelligence in drug discovery.
Subscribe
Recommendations
Andrii’s Substack
Andrii Buvailo, PhD
BridgePoint Bio Newsletter
Subscribe
About
Archive
Recommendations
Sitemap
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
